Articles From: Gilead says EU Committee to recommend approval of leukemia drug to Gladstone Commercial Corporation Earnings Call and Webcast Information


NEW YORK (MarketWatch) -- Gilead Sciences Inc. (GILD) said Friday that a key committee of the European Medicines Agency (EMA) is recommending that its Zydelig treatment for leukemia be approved for use in the 28 countries of the European Union.
Sign-up for Gilead says EU Committee to recommend approval of leukemia drug investment picks
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2014.
Sign-up for Gilead Sciences Announces Second Quarter 2014 Financial Results investment picks
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from two upcoming investor conferences: the Robert W.
Sign-up for Gilead Sciences to Present at Two Upcoming Investor Conferences in September investment picks
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2014 financial results will be released on Wednesday, July 23, at 4:05 p.m. Eastern Time.
Sign-up for Gilead Sciences to Release Second Quarter 2014 Financial Results on Wednesday, July 23, 2014 investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has submitted a New Drug Application (NDA) to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
Sign-up for Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C investment picks
LOS ANGELES (MarketWatch) -- Gilead Sciences Inc. (GILD) said Wednesday that second-quarter net income was $3.66 billion, or $2.20 a share, compared with $772 million, or 46 cents a share, for the same period a year ago.
Sign-up for Gilead trounces estimates for earnings, sales, Sovaldi investment picks
By Tim Mullaney Today's earnings report from Gilead Sciences will be closely watched on both Wall Street and Capitol Hill, where the argument about how much the world's second-most-valuable biotech company should charge for its new $84,000 hepatitis C drug Sovaldi is getting more and more heated.
Sign-up for Gilead's earnings report affects every American investment picks
2014/7/11
Today, Gillette (NYSE: PG), the world’s leading male grooming brand announced a unique twist to this year’s Gillette Home Run Derby (Monday, July 14, live on ESPN at 8:00 pm ET, #HRDerby), which could push the final charitable donation to be the highest in the history of the event.
Sign-up for Gillette Adds Unique Twist to the Gillette Home Run Derby by Challenging Players to Hit #FlexBall Razor Targets and Help Achieve a Potential All-Time High Charitable Donation investment picks
2014/6/23
This summer, Gillette Venus , the #1 selling female razor brand in the world, is asking women to embrace their spontaneous side and celebrate all the on-the-go and leg-baring moments this season brings.
Sign-up for Gillette® Venus Partners with YouTube Star Tessa Violet, Inspiring Women to Be Spontaneous In A Snap investment picks
2014/8/6
NCR Corporation , the global leader in consumer transaction technologies, announced today that Ginsberg’s Foods has selected NCR Power Menu software, enabling the regional foodservice distributor to automatically calculate the nutritional data of prepared foods based on ingredients.
Sign-up for Ginsberg’s Foods Unlocks Business Opportunities and Gains Real-Time Insight with NCR Power Menu Software investment picks
2014/6/18
Imagine a world with no milk, yogurt, or butter.
Sign-up for Give Bees a Chance – The Dairy Aisle Needs Pollinators, Too investment picks
2014/8/20
STAMFORD, Conn.
Sign-up for Give Me an M. Give Me an O.V.I.E Cheers for Charter On Demand Back-to-School Movies investment picks
2014/7/23
Toyota Awards New Prius to Deserving Community Leader LOS ANGELES , July 23, 2014 /PRNewswire/ -- Little did Audrey Moscosa-Rodriguez know that her answer to the question, "where would you go in a new Toyota Prius and why?" would earn her a new hybrid to help her efforts.
Sign-up for Giving to the Giving investment picks
2014/7/29
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Earnings reports pushed these companies to notable moves in European trading on Tuesday, with bank shares in focus.
Sign-up for GKN, Renault among European stocks on the move investment picks
2014/7/24
HIGHLIGHTS: All time record net income of $28.7 million for the current quarter, an increase of 7 percent from the prior quarter net income of $26.7 million and an increase of 26 percent from the prior year second quarter net income of $22.7 million.
Sign-up for Glacier Bancorp, Inc. Announces Results for the Quarter Ended June 30, 2014 investment picks
KALISPELL, Mont., July 8, 2014 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc. (Nasdaq:GBCI) will report second quarter financial results after the market closes on July 24, 2014.
Sign-up for Glacier Bancorp, Inc. Announces Second Quarter Earnings Release and Conference Call investment picks
KALISPELL, Mont., June 25, 2014 (GLOBE NEWSWIRE) -- Glacier Bancorp, Inc.'s (Nasdaq:GBCI) Board of Directors, at a meeting held on June 25, 2014, declared a quarterly dividend of $.17 per share, an increase of $.01 per share, or 6%. The Company has declared 117 consecutive quarterly dividends and has increased the dividend 37 times.
Sign-up for Glacier Bancorp, Inc. Increases Quarterly Dividend investment picks
2014/8/26
Glacier Water Services, Inc. (OTC Pink:GWSV) announced results for the second quarter of the fiscal year 2014, ended June 29, 2014.
Sign-up for Glacier Water Announces Second Quarter Fiscal Year 2014 Results investment picks
MCLEAN, Va., July 15, 2014 (GLOBE NEWSWIRE) -- Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") announced today that its board of directors declared the following monthly cash distributions and also announced its plan to report earnings for the third fiscal quarter ended June 30, 2014.
Sign-up for Gladstone Capital Announces Monthly Cash Distributions for July, August and September, 2014, and Third Quarter Earnings Release and Conference Call Dates investment picks
MCLEAN, Va., July 29, 2014 (GLOBE NEWSWIRE) -- Gladstone Capital Corporation (Nasdaq:GLAD) announces the following event: A conference call replay will be available after the call and will be accessible through August 31, 2014.
Sign-up for Gladstone Capital Corporation Earnings Call and Webcast Information investment picks
MCLEAN, Va., Aug.
Sign-up for Gladstone Capital Corporation Invests in Southern Petroleum Laboratories, Inc. investment picks
MCLEAN, Va., Aug.
Sign-up for Gladstone Capital Corporation Regretfully Reports Death of Board Member investment picks
MCLEAN, Va., July 30, 2014 (GLOBE NEWSWIRE) -- Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") today announced earnings for its third quarter ended June 30, 2014.
Sign-up for Gladstone Capital Corporation Reports Financial Results for the Quarter Ended June 30, 2014 investment picks
MCLEAN, Va., July 31, 2014 (GLOBE NEWSWIRE) -- Gladstone Commercial Corporation (Nasdaq:GOOD) (the "Company") reported today that it closed a $5.6 million second mortgage development loan for the construction of an 81,371 square foot, build-to-suit transitional care facility located on a major hospital campus in Phoenix, Arizona.
Sign-up for Gladstone Commercial Corporation Announces Closing of Development Loan for Healthcare Facility in Phoenix, AZ investment picks
MCLEAN, Va., July 15, 2014 (GLOBE NEWSWIRE) -- Gladstone Commercial Corporation (Nasdaq:GOOD) (the "Company") announced today that its board of directors declared the following monthly cash distributions and also announced its plan to report earnings for the second quarter ended June 30, 2014: Cash Distributions: Common Stock: $0.125 per common share for each of July, August and September, 2014, payable per Table 1 below.
Sign-up for Gladstone Commercial Corporation Announces Monthly Cash Distributions for July, August and September, 2014, and Second Quarter Earnings Release and Conference Call Dates investment picks
MCLEAN, Va., July 7, 2014 (GLOBE NEWSWIRE) -- Gladstone Commercial Corporation (Nasdaq:GOOD) (the "Company") reported today that it purchased a 124,800 square foot building in the Denver suburb of Aurora, Colorado.
Sign-up for Gladstone Commercial Corporation Announces Property Acquisition in Denver Suburb of Aurora, CO investment picks
MCLEAN, Va., Sept.
Sign-up for Gladstone Commercial Corporation Announces Property Acquisition in Indianapolis, IN investment picks
MCLEAN, Va., June 23, 2014 (GLOBE NEWSWIRE) -- Gladstone Commercial Corporation (Nasdaq:GOOD) (the "Company") reported today that it sold its 540,000 square foot industrial property located in Sterling Heights, MI for $11.4 million, representing a gain on sale of approximately $1.2 million.
Sign-up for Gladstone Commercial Corporation Announces Sale of Property in Sterling Heights, MI investment picks
MCLEAN, Va., July 28, 2014 (GLOBE NEWSWIRE) -- Gladstone Commercial Corporation (Nasdaq:GOOD) announces the following event: A conference call replay will be available after the call and will be accessible through August 30, 2014.
Sign-up for Gladstone Commercial Corporation Earnings Call and Webcast Information investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Gilead says EU Committee to recommend approval of leukemia drug to Gladstone Commercial Corporation Earnings Call and Webcast Information
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices